Related Experiment Video
Updated: Jul 11, 2026
08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
New oxazolidinones.
1Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA. Josyula.Varaprasad@Pfizer.com
Current Opinion in Microbiology
|October 12, 2007
Summary
New antibacterials are crucial due to rising antibiotic resistance. Oxazolidinones show promise against resistant bacteria, but linezolid
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Microbiology
Background:
- Antibiotic resistance in pathogens like Staphylococcus and Pseudomonas necessitates novel antibacterial discovery.
- Oxazolidinones are synthetic antibacterials effective against Gram-positive pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA).
- Linezolid, a leading oxazolidinone, shows efficacy but has limitations due to long-term myelotoxicity.
Purpose of the Study:
- To explore novel oxazolidinone derivatives with improved safety and efficacy profiles.
- To address the challenge of developing oxazolidinones with reduced myelotoxicity compared to linezolid.
- To identify compounds with comparable efficacy and pharmacokinetic properties to linezolid.
Main Methods:
- Synthesis of novel oxazolidinone compounds.
- In vitro evaluation of antibacterial activity against resistant Gram-positive pathogens.
- Assessment of myelotoxicity and pharmacokinetic parameters in preclinical models.
Main Results:
- Identification of oxazolidinone candidates demonstrating potent activity against MRSA and other resistant strains.
- Preliminary data suggesting a potentially improved myelotoxicity profile compared to linezolid.
- Characterization of the pharmacokinetic properties of lead compounds.
Conclusions:
- Developing oxazolidinones with reduced myelotoxicity and linezolid-like efficacy remains a significant challenge.
- Further research is needed to optimize lead compounds for clinical development.
- Novel oxazolidinones hold potential for treating infections caused by drug-resistant Gram-positive bacteria.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
00:57Antibiotic Selection
Overview
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...